On day 0, when tumor sizes were an average of 200 mm3 (~10 days post-injection), both wild-type and Per1/2−/− mice were subdivided randomly into three treatment groups: saline, cisplatin treatment at ZT0 (morning), or cisplatin treatment at ZT12 (evening). This evidence concerns the gene PER1 and neoplasm.